Target intelligence / Profile preview

Bacterial membrane phospholipids and lipopolysaccharides (LPS)

Target
LPS
Molecular classification
Lipid, Glycolipid, Other
01

Overview

Bacterial membranes, consisting of phospholipids and lipopolysaccharides (LPS), serve as critical structural barriers and functional interfaces between the bacterium and its environment (Maldonado et al., 2016). In Gram-negative bacteria, the outer membrane is uniquely characterized by the presence of LPS, also known as endotoxin, which provides a robust permeability barrier against many antibiotics and host immune factors (Poirel et al., 2017). The cytoplasmic membrane, present in both Gram-positive and Gram-negative bacteria, is primarily composed of phospholipids and is essential for maintaining ion gradients and energy production (Humphries et al., 2013). These components are vital therapeutic targets; for instance, polymyxins bind to the lipid A portion of LPS and phospholipids to disrupt the outer membrane, while daptomycin inserts into the cytoplasmic membrane of Gram-positive bacteria (Tran et al., 2015). Targeting these structures is a key strategy for treating multidrug-resistant infections, although it carries risks of toxicity due to similarities with host cell membranes or high systemic inflammatory responses triggered by LPS release (Falagas & Kasiakou, 2005). Disruption of these membranes leads to rapid loss of cellular contents and cessation of metabolic processes, making them effective targets for bactericidal agents (Moffatt et al., 2019).

Other names
Bacterial cell envelope lipidsEndotoxinLipid ABacterial outer membraneCytoplasmic membrane lipids
02

Mechanism of action

Binding to and disruption of the bacterial cell membrane, leading to increased permeability, loss of membrane potential, and cell lysis.

03

Biological functions

Structural integrityPermeability barrierIon homeostasisImmune activationOther
04

Disease associations

InfectionInflammationOther
05

Safety considerations

NephrotoxicityNeurotoxicityRhabdomyolysisJarisch-Herxheimer reaction
06

Interacting drugs

Polymyxin B

5 more in the full profile.

07

Biomarkers

Endotoxin levelsProcalcitoninC-reactive protein

Beyond the preview

Go deeper on Bacterial membrane phospholipids and lipopolysaccharides (LPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial membrane phospholipids and lipopolysaccharides (LPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call